Reversible lymphocyte anergy during IL-2 therapy.
Fortis
C
C
Clementi
E
E
D000818:Animals; D017635:Clonal Anergy / Q000187:drug effects*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects*
D007376:Interleukin-2; D011994:Recombinant Proteins